271 related articles for article (PubMed ID: 22101393)
1. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
2. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.
Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.
Gusain A; Hatcher JF; Adibhatla RM; Wesley UV; Dempsey RJ
Mol Neurobiol; 2012 Jun; 45(3):455-64. PubMed ID: 22415444
[TBL] [Abstract][Full Text] [Related]
5. Protection by D609 through cell-cycle regulation after stroke.
Adibhatla RM; Hatcher JF
Mol Neurobiol; 2010 Jun; 41(2-3):206-17. PubMed ID: 20148315
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?
Luberto C; Hannun YA
J Biol Chem; 1998 Jun; 273(23):14550-9. PubMed ID: 9603970
[TBL] [Abstract][Full Text] [Related]
7. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Singh AT; Radeff JM; Kunnel JG; Stern PH
Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
[TBL] [Abstract][Full Text] [Related]
9. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
Girón-Calle J; Srivatsa K; Forman HJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
[TBL] [Abstract][Full Text] [Related]
10. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
[TBL] [Abstract][Full Text] [Related]
11. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide-stimulated human alveolar macrophages.
Monick MM; Carter AB; Gudmundsson G; Mallampalli R; Powers LS; Hunninghake GW
J Immunol; 1999 Mar; 162(5):3005-12. PubMed ID: 10072552
[TBL] [Abstract][Full Text] [Related]
12. Functional role of phosphatidylcholine-specific phospholipase C in regulating leukotriene synthesis and degranulation in human eosinophils.
Sano A; Sano H; Iwanaga T; Tohda Y
Eur J Pharmacol; 2020 Oct; 884():173353. PubMed ID: 32707189
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the role of phosphatidylcholine-specific phospholipase in experimental subarachnoid hemorrhage in rats.
Li B; Li H; Wang Z; Wang Y; Gao A; Cui Y; Liu Y; Chen G
Exp Neurol; 2015 Oct; 272():145-51. PubMed ID: 25743218
[TBL] [Abstract][Full Text] [Related]
14. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
Kiss Z; Tomono M
Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
[TBL] [Abstract][Full Text] [Related]
15. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
[TBL] [Abstract][Full Text] [Related]
16. Development, synthesis and biological investigation of a novel class of potent PC-PLC inhibitors.
Pilkington LI; Sparrow K; Rees SWP; Paulin EK; van Rensburg M; Xu CS; Langley RJ; Leung IKH; Reynisson J; Leung E; Barker D
Eur J Med Chem; 2020 Apr; 191():112162. PubMed ID: 32101781
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein-mediated cellular lipid release requires replenishment of sphingomyelin in a phosphatidylcholine-specific phospholipase C-dependent manner.
Ito J; Nagayasu Y; Ueno S; Yokoyama S
J Biol Chem; 2002 Nov; 277(47):44709-14. PubMed ID: 12228236
[TBL] [Abstract][Full Text] [Related]
18. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Amtmann E
Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide.
Zhang F; Zhao G; Dong Z
Int Immunopharmacol; 2001 Jul; 1(7):1375-84. PubMed ID: 11460317
[TBL] [Abstract][Full Text] [Related]
20. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis.
Zhang L; Zhao J; Su L; Huang B; Wang L; Su H; Zhang Y; Zhang S; Miao J
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):411-8. PubMed ID: 20139365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
